PTO- 1478 |
Approved for use through 10/31/2024. OMB 0651-0009 |
U.S. Patent and Trademark Office; U.S. DEPARTMENT OF COMMERCE Under the Paperwork Reduction Act of 1995, no persons are required to respond to a collection of information unless it contains a valid OMB control number |
Serial Number: 97431737 |
Filing Date: 05/27/2022 |
Input Field |
Entered |
SERIAL NUMBER | 97431737 |
---|---|
MARK INFORMATION | |
*MARK | AIRISFLO |
STANDARD CHARACTERS | YES |
USPTO-GENERATED IMAGE | YES |
LITERAL ELEMENT | AIRISFLO |
MARK STATEMENT | The mark consists of standard characters, without claim to any particular font style, size, or color. |
REGISTER | Principal |
APPLICANT INFORMATION | |
*OWNER OF MARK | AstraZeneca AB |
*MAILING ADDRESS | Astraallén |
*CITY | Södertälje |
*COUNTRY/REGION/JURISDICTION/U.S. TERRITORY | Sweden |
*ZIP/POSTAL CODE (Required for U.S. and certain international addresses) |
SE-15185 |
PHONE | 302-886-6926 |
FAX | 302-885-3762 |
*EMAIL ADDRESS | XXXX |
LEGAL ENTITY INFORMATION | |
TYPE | aktiebolag (ab) |
STATE/COUNTRY/REGION/JURISDICTION/U.S. TERRITORY WHERE LEGALLY ORGANIZED | Sweden |
GOODS AND/OR SERVICES AND BASIS INFORMATION | |
INTERNATIONAL CLASS | 005 |
*IDENTIFICATION | Pharmaceutical preparations and substances |
FILING BASIS | SECTION 1(b) |
FILING BASIS | SECTION 44(d) |
FOREIGN APPLICATION NUMBER | 018678616 |
FOREIGN APPLICATION COUNTRY/REGION/JURISDICTION/U.S. TERRITORY |
European Union Trademark - EUTM |
FOREIGN FILING DATE | 03/29/2022 |
INTENT TO PERFECT 44(d) |
At this time, the applicant intends to rely on Section 44(e) as a basis for registration. If ultimately the applicant does not rely on Section 44(e) as a basis for registration, a valid claim of priority may be retained. |
ATTORNEY INFORMATION | |
NAME | Cara M. Kearney |
ATTORNEY DOCKET NUMBER | 104071/US |
ATTORNEY BAR MEMBERSHIP NUMBER | XXX |
YEAR OF ADMISSION | XXXX |
U.S. STATE/ COMMONWEALTH/ TERRITORY | XX |
FIRM NAME | AstraZeneca Pharmaceuticals LP |
STREET | 1800 Concord Pike, A2C |
CITY | Wilmington |
STATE | Delaware |
COUNTRY/REGION/JURISDICTION/U.S. TERRITORY | United States |
ZIP/POSTAL CODE | 19850-5437 |
PHONE | 302-886-6926 |
FAX | 302-885-3762 |
EMAIL ADDRESS | cara.kearney@astrazeneca.com |
CORRESPONDENCE INFORMATION | |
NAME | Cara M. Kearney |
PRIMARY EMAIL ADDRESS FOR CORRESPONDENCE | cara.kearney@astrazeneca.com |
SECONDARY EMAIL ADDRESS(ES) (COURTESY COPIES) | trademarks@astrazeneca.com; johanna.mansilla@astrazeneca.com |
FEE INFORMATION | |
APPLICATION FILING OPTION | TEAS Standard |
NUMBER OF CLASSES | 1 |
APPLICATION FOR REGISTRATION PER CLASS | 350 |
*TOTAL FEES DUE | 350 |
*TOTAL FEES PAID | 350 |
SIGNATURE INFORMATION | |
SIGNATURE | /cmk/ |
SIGNATORY'S NAME | Cara M. Kearney |
SIGNATORY'S POSITION | Attorney of record, Pennsylvania bar member |
SIGNATORY'S PHONE NUMBER | 302-886-6926 |
DATE SIGNED | 05/26/2022 |
SIGNATURE METHOD | Sent to third party for signature |
PTO- 1478 |
Approved for use through 10/31/2024. OMB 0651-0009 |
U.S. Patent and Trademark Office; U.S. DEPARTMENT OF COMMERCE Under the Paperwork Reduction Act of 1995, no persons are required to respond to a collection of information unless it contains a valid OMB control number |
Serial Number: 97431737 |
Filing Date: 05/27/2022 |
The applicant's current Correspondence Information: |
Cara M. Kearney |
PRIMARY EMAIL FOR CORRESPONDENCE: cara.kearney@astrazeneca.com SECONDARY EMAIL ADDRESS(ES) (COURTESY COPIES): trademarks@astrazeneca.com; johanna.mansilla@astrazeneca.com Requirement for Email and Electronic Filing: I understand that a valid email address must be maintained by the applicant owner/holder and the applicant owner's/holder's attorney, if appointed, and that all official trademark correspondence must be submitted via the Trademark Electronic Application System (TEAS). |
|
|